Consistent with this evidence, the selective inhibitor of GluA2-lacking AMPARs IEM-1460 significantly reduced AMPA-induced neuronal death in CJD but not FFI neurons (S2 Fig). This evidence concerns the gene GRIA2 and Creutzfeldt Jacob disease.